SAB Biotherapeutics, Inc 10-K for FY2022
SAB Biotherapeutics, Inc. (SABS)
10-K
2023-04-14
For: 2022-12-31
View Original
Added on
April 10, 2026
About this 10-K
SAB Biotherapeutics, Inc filed this 10-K on April 14, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $23.9M
- down 60.7% from $60.88M a year earlier
- Net loss
- $18.74M
- compared with a net loss of $17.14M a year earlier